Industry Reports
Vetter publishes first sustainability report
Vetter, a global leading Contract Development and Manufacturing Organization (CDMO), has published its first sustainability report. The report underpins the company commitment to sustainable...
Industry Reports
Dr. Reddys Says Russia Sales Booming As Big Pharma Retreats
While many western biopharma businesses have shied away from Russia since its invasion of Ukraine, some of those in India have stepped in to...
Industry Reports
Commercializing Biopharmaceutical Innovation In A New Era
The new era in biopharmaceutical development promises to usher in a slew of breakthrough medicines, including cures for treatment options. More than 7,800 medications...
Industry Reports
Pfizer Shells Out $11.6 Bn. For Biohaven- Largest Since 2016
Pfizer will pay $11.6 billion for migraine medicine manufacturer Biohaven Pharmaceutical, signifying the company's largest acquisition since 2016, as it seeks to expand its...
Industry Reports
Japan Drug Lobby Asserts Pricing Scheme Driving Drug Crisis
For the first time in the week starting May 16th, Japan's three major pharmaceutical trade associations joined forces to call for changes to the...
Industry Reports
Amid Global Setbacks, Indian Pharma Exports Grow In 2021-22
The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in 2021-22, with a phenomenal increase of about $10 billion...
Industry Reports
Samsung Biologics Reports First Quarter 2022 Financial Results
Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the first quarter of fiscal year 2022.
John Rim, CEO...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read